170 related articles for article (PubMed ID: 6657659)
1. Improved lymphocyte transformation in vitro of patients on continuous ambulatory peritoneal dialysis.
Langhoff E; Ladefoged J
Proc Eur Dial Transplant Assoc; 1983; 20():230-5. PubMed ID: 6657659
[TBL] [Abstract][Full Text] [Related]
2. Haemodialysis, continuous ambulatory peritoneal dialysis and cellular immunity.
Collart F; Tielemans C; Dratwa M; Schandene L; Wybran J; Dupont E
Proc Eur Dial Transplant Assoc; 1983; 20():190-4. PubMed ID: 6228939
[TBL] [Abstract][Full Text] [Related]
3. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
[TBL] [Abstract][Full Text] [Related]
4. The effect of maintenance dialysis on lymphocyte function. I. Haemodialysis.
Holdsworth SR; Fitzgerald MG; Hosking CS; Atkins RC
Clin Exp Immunol; 1978 Jul; 33(1):95-101. PubMed ID: 709914
[TBL] [Abstract][Full Text] [Related]
5. In vitro analysis of B lymphocyte function in uraemia.
Degiannis D; Mowat AM; Galloway E; Tsakiris D; Briggs JD; Junor BJ; Parrott DM
Clin Exp Immunol; 1987 Nov; 70(2):463-70. PubMed ID: 3322618
[TBL] [Abstract][Full Text] [Related]
6. Effect of interleukin-2 and methylprednisolone on in vitro transformation of uremic lymphocytes.
Langhoff E; Ladefoged J; Odum N
Int Arch Allergy Appl Immunol; 1986; 81(1):5-11. PubMed ID: 3488966
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte subsets in the course of continuous ambulatory peritoneal dialysis.
Grzegorzewska AE; Leander M
Adv Perit Dial; 2001; 17():10-4. PubMed ID: 11510253
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of immunophenotypic abnormalities in cellular immunity of uremic patients undergoing either hemodialysis or continuous ambulatory peritoneal dialysis.
Griveas I; Visvardis G; Fleva A; Papadopoulou D; Mitsopoulos E; Kyriklidou P; Manou E; Ginikopoulou E; Meimaridou D; Paulitou A; Sakellariou G
Ren Fail; 2005; 27(3):279-82. PubMed ID: 15957543
[TBL] [Abstract][Full Text] [Related]
9. Impairment of innate cellular response to in vitro stimuli in patients on continuous ambulatory peritoneal dialysis.
Ando M; Shibuya A; Yasuda M; Azuma N; Tsuchiya K; Akiba T; Nitta K
Nephrol Dial Transplant; 2005 Nov; 20(11):2497-503. PubMed ID: 16077138
[TBL] [Abstract][Full Text] [Related]
10. Continuous ambulatory peritoneal dialysis and cellular immunity.
Giangrande A; Cantù P; Limido A; de Francesco D; Malacrida V
Proc Eur Dial Transplant Assoc; 1983; 19():372-9. PubMed ID: 6603616
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
[TBL] [Abstract][Full Text] [Related]
12. Muzolimine in patients on chronic hemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD).
Bandiani G; Camaiora E; Nicolini MA; Perotta U
Z Kardiol; 1985; 74 Suppl 2():84-7. PubMed ID: 4002809
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin and uremic toxicity during continuous ambulatory peritoneal dialysis.
Wideröe TE; Sanengen T; Halvorsen S
Kidney Int Suppl; 1983 Dec; 16():S208-17. PubMed ID: 6588251
[TBL] [Abstract][Full Text] [Related]
14. Immunological studies in uremic and kidney transplanted patients.
Langhoff E
Dan Med Bull; 1989 Apr; 36(2):160-75. PubMed ID: 2651030
[TBL] [Abstract][Full Text] [Related]
15. Effects of uraemia and dialysis modality on polymorphonuclear cell apoptosis and function.
Sardenberg C; Suassuna P; Andreoli MC; Watanabe R; Dalboni MA; Manfredi SR; dos Santos OP; Kallas EG; Draibe SA; Cendoroglo M
Nephrol Dial Transplant; 2006 Jan; 21(1):160-5. PubMed ID: 16155068
[TBL] [Abstract][Full Text] [Related]
16. The immune status of the uremic patient: hemodialysis vs CAPD.
Schollmeyer P; Bozkurt F
Clin Nephrol; 1988; 30 Suppl 1():S37-40. PubMed ID: 3052959
[TBL] [Abstract][Full Text] [Related]
17. Host defense mechanisms in continuous ambulatory peritoneal dialysis.
Rubin J; Lin LM; Lewis R; Cruse J; Bower JD
Clin Nephrol; 1983 Sep; 20(3):140-4. PubMed ID: 6605227
[TBL] [Abstract][Full Text] [Related]
18. Impairment of glutathione biosynthetic pathway in uraemia and dialysis.
Alhamdani MS
Nephrol Dial Transplant; 2005 Jan; 20(1):124-8. PubMed ID: 15632350
[TBL] [Abstract][Full Text] [Related]
19. Activation of L-arginine transport in undialysed chronic renal failure and continuous ambulatory peritoneal dialysis patients.
Brunini TM; Roberts NB; Yaqoob MM; Ellory JC; Mann GE; Mendes Ribeiro AC
Clin Exp Pharmacol Physiol; 2006; 33(1-2):114-8. PubMed ID: 16445709
[TBL] [Abstract][Full Text] [Related]
20. Cell-mediated immunity in uremic patients prior to and after 6 months' treatment with continuous ambulatory peritoneal dialysis.
Shohat B; Boner G; Waller A; Rosenfeld JB
Isr J Med Sci; 1986; 22(7-8):551-5. PubMed ID: 3491060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
